Egbert Baumgart, MD
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Procept Biorobotics Corporation at 56.4% of the total. Reporting peaked in 2022 at $757 and has fallen 89.9% since, to $77 in 2024.
Across 23 payments — averaging $52.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$676
- Axonics, Inc.$168
- AbbVie$146
- Medtronic$58
- GE HealthCare$35
- Rochester Medical Corporation$24
- plus $92 from 5 others
What the payments were for
- Travel & lodging$67656%
- Food & beverage$48340%
- Education$403%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 2 | $676 |
| Axonics, Inc. | 7 | $168 |
| AbbVie | 6 | $146 |
| Medtronic | 1 | $58 |
| GE HealthCare | 1 | $35 |
| Rochester Medical Corporation | 1 | $24 |
| Boston Scientific | 1 | $21 |
| Pfizer | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Coloplast | 1 | $17 |
| Caldera Medical, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,200 in reported general payments places this provider in the 60th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 88 | $91,718 |
| Tamsulosin Hcl | 498 | $8,427 |
| Potassium Citrate ErPotassium Citrate | 42 | $7,361 |
| Tolterodine Tartrate ErTolterodine Tartrate | 46 | $6,402 |
| Estradiol | 21 | $5,926 |
| Finasteride | 261 | $4,305 |
| Oxybutynin Chloride ErOxybutynin Chloride | 108 | $2,762 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 95 | $2,049 |
| Testosterone Cypionate | 63 | $1,710 |
| Cefpodoxime Proxetil | 24 | $1,298 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 44 | $885 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 141 | $418 |
| Dutasteride | 12 | $377 |
| Cephalexin | 30 | $344 |
| Chlorthalidone | 12 | $308 |
Paid to pharmacies, not to this prescriber.
Other urology in Dover
- Shilpa LambaDover$2K
- James BettiDover$2K
- Cormac OneillDover$2K
- Eric RaffinDover$522
- Sandy ChinDover$507
- Michael MichaelsDover$68
- Martin GrossKeene$172K
- Ramiro Madden-FuentesConcord$82K
- Jason AkermanManchester$53K
- Lori LernerLebanon$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.